These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 23674264

  • 1. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B, Hanley J, Lai J, Vourganti S, Kim SP, Setodji CM, Dick AW, Chow WH, Saigal C, Urologic Diseases in America Project.
    Cancer; 2013 Aug 15; 119(16):2981-9. PubMed ID: 23674264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M, Bratslavsky G.
    Urol Oncol; 2014 Jul 15; 32(5):549-54. PubMed ID: 24495447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr 15; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC.
    Cancer; 2018 Oct 01; 124(19):3839-3848. PubMed ID: 30207380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL, Hayn MH, Brewer KA, Underwood W, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T.
    World J Urol; 2015 Nov 01; 33(11):1807-14. PubMed ID: 25805189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
    Takagi T, Kondo T, Iizuka J, Omae K, Kobayashi H, Yoshida K, Hashimoto Y, Tanabe K.
    BJU Int; 2016 Jun 01; 117(6B):E52-9. PubMed ID: 26073989
    [Abstract] [Full Text] [Related]

  • 14. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N, Cranston D, Akhtar MZ, George C, Jones A, Leiblich A, Protheroe A, Sullivan M.
    BJU Int; 2012 Nov 01; 110(9):1270-5. PubMed ID: 22564495
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M, Kokabi N, Zhang D, Ludwig JM, Kim HS.
    Radiology; 2018 Jul 01; 288(1):81-90. PubMed ID: 29737950
    [Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.
    Eur Urol; 2012 Jun 01; 61(6):1156-61. PubMed ID: 22257424
    [Abstract] [Full Text] [Related]

  • 18. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V, Koru-Sengul T, Miao F, Nahar B, Prakash NS, Swain S, Punnen S, Ritch C, Gonzalgo M, Parekh D.
    Urol Oncol; 2018 Mar 01; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [Abstract] [Full Text] [Related]

  • 19. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, Saad F, Patard JJ, Montorsi F, Karakiewicz PI.
    Cancer; 2009 Apr 01; 115(7):1465-71. PubMed ID: 19195042
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
    Talenfeld AD, Gennarelli RL, Elkin EB, Atoria CL, Durack JC, Huang WC, Kwan SW.
    Ann Intern Med; 2018 Jul 17; 169(2):69-77. PubMed ID: 29946703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.